pain

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

https://pharmaphorum.com/news/beckley-canopy-therapeutics-raises-7-4m-for-cannabis-rd/

Trump signs legislation to tackle opiate addiction

https://pharmaphorum.com/news/trump-signs-legislation-to-tackle-opiate-addiction/

New US legislation aims to expedite development of non-opioid pain drugs

https://pharmaphorum.com/news/new-us-legislation-aims-to-expedite-development-of-non-opioid-pain-drugs/

FDA approves Teva’s higher-dose opioid dependence therapy

https://pharmaphorum.com/news/fda-approves-tevas-higher-dose-opioid-dependence-therapy/

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

https://pharmaphorum.com/news/pfizer-lilly-tanezumab-pain-drug-hits-mark-in-phase-3-trial/

Pacira CEO hopes for further expansion to US nerve block label

https://pharmaphorum.com/news/pacira-hopes-expansion-nerve-blocker-label-us/

FDA advisers reject new use for Pacira nerve block

https://pharmaphorum.com/news/fda-advisers-reject-new-use-pacira-nerve-block/

SMi’s Pain Therapeutics Conference

www.pain-therapeutics.co.uk/phphorum

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search